Combine searches by placing the search numbers in the top search box and pressing the search button. An example search might look like (#1 or #2) and (#3 or #4)
Latest & greatest articles for Tinea Corporis
The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on Tinea Corporis or other clinical topics then use Trip today.
This page lists the very latest high quality evidence on Tinea Corporis and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.
What is Trip?
Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.
Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.
As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.
For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via firstname.lastname@example.org
TineaCorporis Infection - Guidelines for Prescribing Topical Antifungals TineaCorporis Infection - Guidelines for Prescribing Topical Antifungals - medSask Home - College of Pharmacy and Nutrition - University of Saskatchewan Toggle Menu Search the U of S Search TineaCorporis Infection - Guidelines for Prescribing Topical Antifungals Fungal or tinea infections of the skin are common, with tineacorporis (ringworm) and tinea cruris (jock itch) affecting 10 to 20% of the general population (...) at some point in their lifetime and up to 44% of wrestlers (known as tineacorporis gladiatorum) Men are more often affected than women Superficial fungal infections of the skin are caused by three dermatophytes; Trichophyton, Epidermophyton and Microsporum which use the keratin layer of the epidermis as their source of nutrition Tinea infection is classified by location on the body, not by the causative organism Tinea infections are contagious and are spread by skin-to-skin contact with infected
Tineacorporis in a wrestling team cheerleader 28492027 2019 02 26 2352-6475 2 4 2016 Dec International journal of women's dermatology Int J Womens Dermatol Tineacorporis in a wrestling team cheerleader. 143-144 10.1016/j.ijwd.2016.10.001 McClanahan C C Department of Dermatology, University of Iowa. Wanat K K Department of Dermatology, University of Iowa. eng Case Reports 2016 12 06 Netherlands Int J Womens Dermatol 101654170 2352-6475 athlete cheerleader skin infection tineatinea gladiatorum
Topical antifungal treatments for tinea cruris and tineacorporis. Tinea infections are fungal infections of the skin caused by dermatophytes. It is estimated that 10% to 20% of the world population is affected by fungal skin infections. Sites of infection vary according to geographical location, the organism involved, and environmental and cultural differences. Both tineacorporis, also referred to as 'ringworm' and tinea cruris or 'jock itch' are conditions frequently seen by primary care (...) ), MEDLINE (from 1946), EMBASE (from 1974), and LILACS (from 1982). We also searched five trials registers, and checked the reference lists of included and excluded studies for further references to relevant randomised controlled trials. We handsearched the journal Mycoses from 1957 to 1990.Randomised controlled trials in people with proven dermatophyte infection of the body (tineacorporis) or groin (tinea cruris).Two review authors independently carried out study selection, data extraction, assessment
Luzu (luliconozole) - For the topical treatment of interdigital tinea pedis, tinea cruris, and tineacorporis caused by the organisms Trichophyton rubrum and Epidermophyton floccosum, in patients 18 years of age and older Drug Approval Package: Brand Name (Generic Name) NDA # Drug Approval Package U.S. Food & Drug Administration Search FDA Drug Approval Package - LUZU (luliconazole) Cream Company: Medicis Pharmaceutical Corporation Application No.: 204153 Approval Date: 11/14/2013 Persons